Диссертация (1145006), страница 44
Текст из файла (страница 44)
Roger, A.S. Go, D.M. Lloyd-Jones [et al.] //Circulation. –2011. – Vol. 123, Iss. 4 – P. e18 – e209.195. Heart Disease and Stroke Statistics 2012 Update: A Report From the AmericanHeart Association /V.L. Roger, A.S. Go, D.M. Lloyd-Jones [et al.] //Circulation.– 2012. – Vol. – 125. - P. e2-e220.196. Heart disease and stroke statistics – 2013 update: a report from the AmericanHeart Association /A.S. Go, D. Mazzafarian, V.L.
Roger [et al.] //Circulation. 2013. - Vol. 127, № 1. - P. 143 - 152.197. Heart disease and stroke statistics--2014 update: a report from the AmericanHeart Association /A.S. Go, D. Mozaffarian, V.L. Roger [et al.] //Circulation. –2014. – Vol. 129, № 3. – P. e28 - e29.198. Hemodynamic and renal responses in physiological levels of ANF in consciousdog /R. Pichet, M.
Cantin, G. Thibault [et al.] //J. Hypertens. - 1989. - Vol. 14. - P.104 – 110.199. Human umbilical vein endothelial cells express complement receptor-1 (CD35)and complement receptor-4 (CD11c/CD18) in vitro /H. Langeggen, K.E. Berge, E.Johnson [et al.] //Inflammation. – 2002. – Vol. 3. – P. 103 - 110.272200. Hypertensive nephropathy in children — do we diagnose early enough? /A.Blumczynski. J. Sołtysiak, K. Lipkowska [et al.] //Blood Press. - 2012 Aug. - Vol.21, № 4. - P.
233 - 239.201. Imaging Atherosclerosis and Vulnerable Plaque /М.М.Sadeghi1, D.K. Glover,G.M. Lanza. [et al.] //J. Nucl. Med. - 2010. - Vol. 51, Suppl. 1. - P. 51 - 65.202. Impact of acute renal failure following percutaneous coronary intervention onlong-term mortality /A. Roghi, S. Savonitto, C. Cavallini [et al.] //J. Cardiovasc.Med. – 2008. - Vol.
9. – P. 375 - 381.203. Impact of minimal increases in serum creatinine on outcome in patients aftercardiothoracic surgery: do we have to revise current definitions of acute renalfailure? /A. Lassnigg, E.R. Schmid, M. Hiesmayr [et al.] //Crit. Care Med. – 200. –Vol. 36. – P. 1129 - 37.204.
Impact of nephropathy after percutaneous coronary intervention and a metod forrisk stratification /В.A. Barthoomew, K.J. Harjai, S. Dukkipati [et al.] //Am. J.Cardiol. - 2004. - Vol. 93. - P. 1515 - 1519.205. Improving Global Outcomes (KDIGO) Acute Kidney Injury. KDIGO ClinicalPractice Guideline for Acute Kidney Injury /J. A Kellum, P. Aspelin, R. S. Barsoum[et al.] //Kidney Int. - 2012. - Vol. 2, Suppl. 1. - P. 1 - 138.206. Improving long-term risk prediction in patients with acute chest pain: the GlobalRegistry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers /K.M.
Eggers, T. Kempf, P. Venge [et al.] //Am. Heart J. 2010. – Vol. 160. - P. 88 – 94.207. Incidence and relevance of acute kidney injury in patients hospitalized with acutecoronary syndromes /G. Marenzi, A. Cabiati, S.V. Bertoli [et al.] //Am. J. Cardiol. –2013. - Vol. 111. - № 1. - P. 816 - 822.208. Increase in Creatinine and Cardiovascular Risk in Patients with SystolicDysfunction after Myocardial Infarction /P.
Jose, H. Skali, N. Anavekar [et al.] //J.Am..Soc. Nephrol. - 2006. - Vol. 17. - P. 2886 - 2891.273209. Incidence, Predictors, and Outcome of Thrombosis After Successful Implantationof Drug-Eluting Stents /I. Iakovou, T. Schmidt, E. Bonizzoni [et al.] //JAMA. –2005. - Vol. 293. - P. 2126 - 2130.210. Increased prevalence of coronary artery disease, silent myocardial ischemia,complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy,mitral annular calcium, and aortic valve calcium in patients with chronic renalinsufficiency /M.
Das, W.S. Aronow, J.A. Mc Clung [et al.] //Cardiol. Rev. - 2006.- Vol. 14. - P. 14 - 17.211. Increased risk of myocardial infarction and stroke following exacerbation ofCOPD /G.C. Donaldson, J.R. Hurst, C.J. Smith [et al.] //Chest. – 2010. – Vol.137,№ 5. – P. 1091 - 1097.212. Increased urinary albumin excretion, endothelial dysfunction, and chronic lowgrade inflammation in type 2 diabetes: progressive, interrelated, and independentlyassociated with risk of death /C.D.
Stehouwer, M.A. Gall, J.W. Twisk, [et al.]//Diabetes. – 2002. – Vol. 51. – P. 1157 - 1165.213. Inflammation and coagulation markers and kidney function decline: the MultiEthnic Study of Atherosclerosis (MESA) /J.S. Hiramoto, R. Katz, C.A. Peralta [etal.] //Am. J. Kidney Dis. - 2012 Aug.
- Vol. 60, N 2.- P. 225 – 32.214. Intravenous NPA for the treatment of infracting myocardium early: InTIME II, adouble-blind comparison of single-bolus lanoteplase vs accelerated alteplase for thetreatment of patients with acute myocardial infarction/F. Van de Werf, D.Ardissino, A. Betriu [et al.] //Eur.
Heart J.- 2000. - Vol. 21, № 24. - P. 2005 - 2013.215. Juffe, A.S., Babuin L., Apple F.S. Biomarkers in acute cardiac disease /A.S.Juffe, L. Babuin, F.S. Apple //J. Am. Coll. Cardiol. - 2006. - Vol. 48. - P. 1-11.216. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management ofChronic Kidney Disease //Kidney Int. (Suppl.). - 2013.- Vol.
3. - P. 1 - 150.217. KDOQI US commentary on the 2012 KDIGO clinical practice guaideline foracute kidney injury /P.M. Paevsky, K.D. Liu, P.D. Brophy [et al.] //Am. J. KidneyDis. – 2013. - Vol. 61. - P. 649 - 672.274218. Khot, U.N. Prognostic importance of physical examination for heart failure innon-ST-elevation acute coronary syndromes: the enduring value of Killipclassification /U.N. Khot, G. Jia, D.J. Moliterno [et al.] //JAMA. - 2003. – Vol.290. – P. 2174 – 2181.219.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group.KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management ofChronic Kidney Disease //Kidney Int. Suppl. – 2013. – Vol. 3. – P. 1 - 150.220. Kidney disease as a risk factor for development of cardiovascular disease: astatement from the American Heart Association Councils on Kidney inCardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, andEpidemiology and Prevention /M.J. Sarnak, A.S. Levey, A.C. Schoolwerth [et al.]//Circulation. - 2003. - Vol. 108. - P.
2154 - 2169.221. Kidney injury molecule-1 is a phosphatidylserine receptor that confers aphagocytic phenotype on epithelial cells /T. Ichimura, E.J. Asseldonk, B.D.Humphreys B.D. [et al.] //J. Clin. Invest. - 2008. - Vol. 118. - P. 1657-1668.222. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximaltubule injury /W.K.
Han, V. Bailly, R. Abichandani [et al.] //Kidney International. 2002. - Vol. 62, № 1. - P. 237 - 244.223. Late thrombosis of drugeluting stents: a metaanalysis of randomized clinical trials/A.A. Bavry, D.J. Kumbhani, T.J. Helton [et al.] //Am. J. Med. 2006. - Vol.
119. - P.1056 -1061.224. Left ventricular mass index increase in early renal disease: impact of decline inhemoglobin /A. Levin, C.R. Thompson, J. Ethier [et al.] //Am. J. Kidney Dis. 1999. - Vol. 34. - P. 125 - 134.225. Level of kidney function as a risk factor for atherosclerotic cardiovascularoutcomes in the community /G. Manjunath, H. Tighiouart, H. Ibrahim [et al.] //J.Am. Coll. Cardiol.
- 2003. - Vol. 41, №1. - P. 47 - 55.226. Levin, A. Cardiovascular disease in chronic renal insufficiency /A. Levin, R.N.Foley //Am. J. Kidney Dis.- 2000. – Vol. 36. - S. 24–30.275227. Leukocyte count and coronary heart disease. Implications for risk assessment/М. Madjid, I.
Awan, J.T. Willerson [et al.] //J. Am. Coll. Cardiol. - 2004. - Vol.44. - P. 1945–1956.228. Leukocytosis and adverse hospital outcomes after acute myocardial infarction /R.Goldberg, V. Menon, D. Lessard [et al.] //Am. J. Cardiol. - 2003. - Vol. 92. - P.368-372.229. Liaudet, L. Role of innate immunity in cardiac inflammation after myocardialinfarction /L. Liaudet, N.
Rosenblatt-Velin //Front. Biosci. (Schol. Ed.). – 2013. –Vol.5. – P. 86-104.230. Libby, P. Inflammation in atherosclerosis. From pathophysiology to practice /P.Libby, M.P. Ridker, K.G. Hansson //J. Am. Coll. Cardiol. - 2009.- Vol. 54. - P. 2129.231. Liu, P.P. Cardiorenal syndrome in heart failure: a cardiologists perspective /P.P.Liu //Can. J. Cardiol. - 2008. - Vol, № 24, Suppl. B. - P. 25B – 29B.232. Long term clinical outcomes in patients with moderate renal insufficiencyundergoing stent based percutaneous coronary intervention /R.Y. Zhang, J.W.
Ni,J.S. Zhang [et al.] //Chin. Med. J. (Engl.). - 2006. - Vol. 20, № 119. - P. 1176 - 1181.233. Lubos, E. Role of oxidative stress and nitric oxide in atherothrombosis /E.Lubos, D.E. Handy, J. Loscalzo //Front. Biosci. - 2009. - Vol. 13. - P. 5323 - 5344.234. Mahaffey, K.W. The Superior Yield of the New Strategy ofEnoxaparin,Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) Trial: PrimaryResults /K.W.
Mahaffey, J.J. Ferguson, R.M. Califf //[Электpoнный pеcуpc].2004.-www.acc04online.org (Дaтa oбpaщения 02.02.2015).235. Makita, Y. Effects of adrenoceptor agonists and antagonists on smooth musclecells and neuromuscular transmission in the guinea-pig renal artery and vein /Y.Makita //Br. J.
Pharmacol. - 1983. - Vol. 80, № 4. - P. 671 - 679.276236. Markers of atherosclerosis and inflammation for prediction of coronary heartdisease in older adults /N. Rodondi, P. Marques-Vidal, J. Butler [et al.] //Am. J.Epidemiol. – 2010. – Vol. 171, № 5. – P. 540 -549.237. Markers of myocardial damage and inflammation in relation to long-termmortality in unstable coronary artery disease. FRISC Study Group. Fragmin duringInstability in Coronary Artery Disease /В. Lindahl, Н. Toss, A. Siegbahn [et al.]//N.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
